哌拉西林-他唑巴坦作为产超广谱β-内酰胺酶的大肠埃希菌和肺炎克雷伯菌所致菌血症的初始经验性治疗药物。 - Suppr

Suppr

超能文献

Piperacillin-tazobactam as an initial empirical therapy of bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae.

作者信息

Kang Cheol-In, Park So Yeon, Chung Doo Ryeon, Peck Kyong Ran, Song Jae-Hoon

出版信息

J Infect. 2012 May;64(5):533-4. doi: 10.1016/j.jinf.2012.01.008. Epub 2012 Jan 16.

DOI:10.1016/j.jinf.2012.01.008

PMID:22274414

Abstract

摘要

相似文献

Piperacillin-tazobactam as an initial empirical therapy of bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae.哌拉西林-他唑巴坦作为产超广谱β-内酰胺酶的大肠埃希菌和肺炎克雷伯菌所致菌血症的初始经验性治疗药物。

J Infect. 2012 May;64(5):533-4. doi: 10.1016/j.jinf.2012.01.008. Epub 2012 Jan 16.

Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta-lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam.产超广谱β-内酰胺酶肠杆菌科细菌治疗的抗生素政策与处方策略：哌拉西林-他唑巴坦的作用

Clin Microbiol Infect. 2008 Jan;14 Suppl 1:181-4. doi: 10.1111/j.1469-0691.2007.01864.x.

Mortality caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae bacteremia; a case control study: alert to Enterobacteriaceae strains with high minimum inhibitory concentrations of piperacillin/tazobactam.产超广谱β-内酰胺酶肠杆菌科菌血症导致的死亡率；病例对照研究：警惕哌拉西林/他唑巴坦最低抑菌浓度高的肠杆菌科菌株。

Diagn Microbiol Infect Dis. 2019 Jul;94(3):287-292. doi: 10.1016/j.diagmicrobio.2019.01.018. Epub 2019 Jan 30.

Current status of extended spectrum β-lactamase-producing Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis in Okinawa prefecture, Japan.日本冲绳县产超广谱β-内酰胺酶大肠埃希菌、肺炎克雷伯菌和奇异变形杆菌的现状

J Infect Chemother. 2016 May;22(5):281-6. doi: 10.1016/j.jiac.2016.01.008. Epub 2016 Feb 15.

Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.产超广谱β-内酰胺酶肠杆菌科细菌所致血流感染患者的死亡预测因素：初始抗菌治疗不充分的重要性

Antimicrob Agents Chemother. 2007 Jun;51(6):1987-94. doi: 10.1128/AAC.01509-06. Epub 2007 Mar 26.

Prevalence and risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae.产超广谱β-内酰胺酶（ESBL）肠杆菌科细菌引起感染的患病率及危险因素

J Infect Chemother. 2016 May;22(5):319-26. doi: 10.1016/j.jiac.2016.02.004. Epub 2016 Mar 8.

Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in febrile neutropenic children.发热性中性粒细胞减少儿童中产超广谱β-内酰胺酶的大肠埃希菌和肺炎克雷伯菌血症

Microb Drug Resist. 2015 Apr;21(2):244-51. doi: 10.1089/mdr.2014.0092. Epub 2014 Nov 14.

Activity of beta-lactam beta-lactamase inhibitor combinations against extended spectrum Beta-lactamase producing Enterobacteriaceae in urinary isolates.β-内酰胺类与β-内酰胺酶抑制剂联合制剂对尿液分离株中产超广谱β-内酰胺酶肠杆菌科细菌的活性

J Coll Physicians Surg Pak. 2012 Jun;22(6):358-62.

Which non-carbapenem antibiotics are active against extended-spectrum β-lactamase-producing Enterobacteriaceae?哪些非碳青霉烯类抗生素对产超广谱β-内酰胺酶的肠杆菌科有效？

Int J Antimicrob Agents. 2018 Jul;52(1):100-103. doi: 10.1016/j.ijantimicag.2018.03.014. Epub 2018 Mar 23.

In vitro susceptibility and distribution of beta-lactamases in Enterobacteriaceae causing intra-abdominal infections in North America 2010-2011.北美 2010-2011 年引起腹腔内感染的肠杆菌科细菌的体外药敏和β-内酰胺酶分布情况。

Diagn Microbiol Infect Dis. 2014 Jul;79(3):367-72. doi: 10.1016/j.diagmicrobio.2014.03.026. Epub 2014 Apr 12.

引用本文的文献

No improvement in mortality among critically ill patients with carbapenems as initial empirical therapy and more detection of multi-drug resistant pathogens associated with longer use: a post hoc analysis of a prospective cohort study.初始经验性碳青霉烯类治疗的危重症患者死亡率无改善，且与更长时间使用相关的多药耐药病原体检出率更高：一项前瞻性队列研究的事后分析。

Microbiol Spectr. 2024 Jul 2;12(7):e0034224. doi: 10.1128/spectrum.00342-24. Epub 2024 Jun 12.

Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use.腹腔内感染的管理：意大利抗菌药物优化使用理事会的建议。

World J Emerg Surg. 2024 Jun 8;19(1):23. doi: 10.1186/s13017-024-00551-w.

Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP.哌拉西林-他唑巴坦与美罗培南优化的药代动力学/药效学目标达成对接受持续输注单药治疗确诊革兰阴性血流感染和/或呼吸机相关性肺炎的重症患者序贯器官衰竭评估（SOFA）评分及炎症生物标志物随时间变化趋势的比较影响

Antibiotics (Basel). 2024 Mar 25;13(4):296. doi: 10.3390/antibiotics13040296.

Real-Time TDM-Guided Optimal Joint PK/PD Target Attainment of Continuous Infusion Piperacillin-Tazobactam Monotherapy Is an Effective Carbapenem-Sparing Strategy for Treating Non-Severe ESBL-Producing Secondary Bloodstream Infections: Findings from a Prospective Pilot Study.实时治疗药物监测（TDM）指导下持续输注哌拉西林-他唑巴坦单药治疗实现最佳联合药代动力学/药效学（PK/PD）目标是一种有效的碳青霉烯类药物节省策略，用于治疗非重症产超广谱β-内酰胺酶（ESBL）的继发性血流感染：一项前瞻性试点研究的结果

Microorganisms. 2024 Jan 12;12(1):151. doi: 10.3390/microorganisms12010151.

Efficacy of Noncarbapenem β-Lactams Compared to Carbapenems for Extended-Spectrum β-Lactamase-Producing Enterobacterales Urinary Tract Infections.与碳青霉烯类药物相比，非碳青霉烯类β-内酰胺类药物治疗产超广谱β-内酰胺酶肠杆菌科细菌引起的尿路感染的疗效

Open Forum Infect Dis. 2022 Feb 14;9(3):ofac034. doi: 10.1093/ofid/ofac034. eCollection 2022 Mar.

Reply: The Efficacy of Penicillins with β-lactamase Inhibitor or Cefmetazole against Pneumonia in which ESBL-Producing Bacteria were Isolated from Sputum.回复：β-内酰胺酶抑制剂复合青霉素或头孢美唑对从痰液中分离出产超广谱β-内酰胺酶细菌的肺炎的疗效。

Infect Chemother. 2021 Sep;53(3):565-567. doi: 10.3947/ic.2021.0306. Epub 2021 Sep 6.

An Evidence-Based Multidisciplinary Approach Focused at Creating Algorithms for Targeted Therapy of BSIs, cUTIs, and cIAIs Caused by in Critically Ill Adult Patients.一种基于证据的多学科方法，专注于为重症成年患者中由[病原体名称未给出]引起的血流感染、复杂性尿路感染和复杂性腹腔内感染创建靶向治疗算法。

Infect Drug Resist. 2021 Jun 30;14:2461-2498. doi: 10.2147/IDR.S314241. eCollection 2021.

Single-dose amikacin plus 7 days of amoxicillin/clavulanate to treat acute cystitis caused by extended-spectrum beta-lactamase-producing : A retrospective cohort study.单剂阿米卡星联合 7 天阿莫西林/克拉维酸治疗产超广谱β-内酰胺酶所致急性膀胱炎：一项回顾性队列研究。

Investig Clin Urol. 2021 May;62(3):310-316. doi: 10.4111/icu.20200240.

Routine Intraoperative Bacterial Culture May Be Needed in Complicated Appendicitis.复杂阑尾炎可能需要常规术中细菌培养。

Ann Coloproctol. 2020 Jun;36(3):155-162. doi: 10.3393/ac.2019.11.04.1. Epub 2020 Jun 30.

Carbapenem-Sparing Strategies for ESBL Producers: When and How.针对产超广谱β-内酰胺酶（ESBL）菌的碳青霉烯类抗菌药物节省策略：时机与方法

Antibiotics (Basel). 2020 Feb 5;9(2):61. doi: 10.3390/antibiotics9020061.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验